Delivery of intravenous anti-cancer therapy at home versus in hospital or community settings for adults with cancer

Nursing and Health Professions

• Malignant Neoplasm 100%
• Cancer Therapy 100%
• Anticancer 100%
• Outpatient Department 25%
• Chemotherapy 25%
• Adverse Event 20%
• Cost Effectiveness Analysis 15%
• Immunotherapy 15%
• Hospital Inpatient 15%
• Accident Prevention 15%
• Receiving Treatment 15%
• Economic Evaluation 10%
• Nurse 10%
• Systematic Review 10%
• Healthcare System 10%
• Clinical Practice 5%
• Emergency Ward 5%
• Home Care 5%
• Cost Benefit Analysis 5%
• General Practice 5%
• Hospital Setting 5%
• CINAHL 5%
• Cochrane Library 5%
• Cost Utility Analysis 5%
• Outpatient 5%
• Embase 5%
• Nonhodgkin Lymphoma 5%
• Infection 5%
• World Health Organization 5%
• Breast Cancer 5%
• Evaluation Study 5%
• Thrombosis 5%
• Colorectal Carcinoma 5%
• Patient Preference 5%
• Cancer Chemotherapy 5%
• Treatment Duration 5%
• Head and Neck Cancer 5%
• Quality of Life 5%
• Adherence 5%

Medicine and Dentistry

• Malignant Neoplasm 100%
• Cancer Treatment 100%
• Health Care Cost 36%
• Hospital Outpatient 26%
• Chemotherapy 26%
• Adverse Event 21%
• Randomized Controlled Trial 15%
• Cost-Effectiveness Analysis 15%
• Systematic Review 15%
• Hospital Inpatient 15%
• Immunotherapy 15%
• Nurse 10%
• Preference 10%
• Evaluation Study 5%
• Breast Cancer 5%
• Colon 5%
• Lung 5%
• Head and Neck Cancer 5%
• Cost Benefit Analysis 5%
• Emergency Department 5%
• General Medicine 5%
• Outpatient 5%
• Cancer 5%
• Infection 5%
• Quality of Life 5%
• Cancer Immunotherapy 5%
• Non-Hodgkin Lymphoma 5%
• Cancer Chemotherapy 5%
• Patient Preference 5%
• Effectiveness Study 5%
• Thrombosis 5%
• Colorectal Carcinoma 5%
• Treatment Duration 5%

Pharmacology, Toxicology and Pharmaceutical Science

• Malignant Neoplasm 100%
• Chemotherapy Regimen 20%
• Immunotherapy 16%
• Adverse Event 16%
• Randomized Controlled Trial 12%
• Preference 12%
• Cancer Chemotherapy 4%
• Effectiveness Study 4%
• Intravenous Therapy 4%
• Breast Cancer 4%
• Colorectal Carcinoma 4%
• Infection 4%
• Nonhodgkin Lymphoma 4%
• Thrombosis 4%
• Head and Neck Cancer 4%